Tracy Bahl: Unifying Interests to Improve Oncology in a Consolidated Way Can Improve Patient Care

November 8, 2019

Consolidating unified interests for improved cancer care can enhance efficiency and quality of care for patients, said Tracy Bahl, MBA, president and chief executive officer of OneOncology.

Consolidating unified interests for improved cancer care can enhance efficiency and quality of care for patients, said Tracy Bahl, MBA, president and chief executive officer of OneOncology.

Transcript

What best practices have emerged for surviving in a market that is seeing more and more consolidation?

Consolidation historically has existed in this almost adversarial context. We have to consolidate as much mass as possible so that we can pit ourselves against, competitively, the rest of the marketplace—so that we can bring greater leverage and greater power in the marketplace. In the end, that kind of consolidation only furthers the adversary relationship that has broken the American healthcare system. Instead, consolidation in the context of something like OneOncology, is designed to bring those economies of scale and economies of intelligence that enable us to align our interest with others who are equally motivated to improve cancer care in their community. So, we get better data, better analytics, and greater affordability for others—whether they be payers, whether they be hospitals, whether they be other community oncology practices or other physicians that share the same mission we do. We can bring that together in a consolidated way and drive greater efficiency and better patient care.